Biotech

All Articles

Former Seagen CEO unveils new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2013 for a tremendou...

Ironwood produces additional bid for $1B GI medicine along with brand new subgroup data

.On the heels of a stage 3 win that neglected to excite clients, Ironwood Pharmaceuticals is actuall...

Novartis inks $150M offer for autoimmune molecular adhesive

.Don't quit Monte Rosa Therapeutics right now. The Boston-based biotech is actually having a ball af...

Jade carves out exec crew along with Chinook vets-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, firings and re...

Septerna goes public with upsized offering of $288M

.Celebrating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer called the position b...

AbbVie brings in Richter richer, paying out $25M to form breakthrough contract

.AbbVie has come back to the source of its antipsychotic giant Vraylar looking for an additional hit...

GenSight enters last weeks of cash path as income flow slips by of range

.GenSight Biologics is actually weeks out of losing amount of money. Again. The biotech just has ade...

AZ licenses thrown out unusual ailment drug to Monopar Therapies

.Monopar Therapies is recouping a medicine from the dump of AstraZeneca's rare disease pipeline. It ...

Arcus' brand-new HIF-2a data in kidney cancer cells mean potential upper hand over Merck's Welireg, experts state

.With new information out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts f...

Roche wagers approximately $1B to increase Dyno gene treatment shipment pact

.After forming a gene therapy collaboration along with Dyno Therapies in 2020, Roche is actually bac...